Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Virology
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1531712

The trend of phylogenetic and epitope variations of SARS-CoV2 Omicron sub-lineages in Iran

Provisionally accepted
Mehdi Shabani Mehdi Shabani 1Ahmad Nejati Ahmad Nejati 1*Jila Yavarian Jila Yavarian 1Kaveh Sadeghi Kaveh Sadeghi 1*Sevrin Zadheidar Sevrin Zadheidar 1*Akram Sadat Ahmadi Akram Sadat Ahmadi 1*Monire Ghadirali Monire Ghadirali 1*Arghavan Zebardast Arghavan Zebardast 1Adel Abedi Adel Abedi 2Mohammad Hossein Najmi Mohammad Hossein Najmi 3*Nazanin-Zahra Shafiei-Jandaghi Nazanin-Zahra Shafiei-Jandaghi 1*Talat Mokhtari-Azad Talat Mokhtari-Azad 1*
  • 1 Tehran University of Medical Sciences, Tehran, Iran
  • 2 Shahid Beheshti University, Tehran, Tehran, Iran
  • 3 Tarbiat Modares University, Tehran, Tehran, Iran

The final, formatted version of the article will be published soon.

    Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a significant public health issue worldwide in recent years. The most recently circulating variant of SARS-CoV-2, Omicron, and its rapid evolution into various sub-lineages have raised concerns regarding the effects of the immunity on the virus epitopes, in the human population. The present study evaluated and compared these important variations among different Omicron sub-lineages in Iran. Methodology: From October 2023 to August 2024, high coverage whole genome sequences of 49 SARS-CoV-2 strains were subjected to phylogenetic analysis and evaluation of B cell, CD4+, and CD8+ T cell epitopes in Iran National Influenza Centre. Results: The phylogenetic tree exhibited eight Nextstrain clades (21L, 22F, 23B, 23H, 23D, 24A, 24B, 24C) in 48 studied strains, and one recombinant strain (XDK.1). The evaluation of B cell, CD4+, and CD8+ T cell epitopes in all studied strains revealed 31%, 65% and 78%, of conservation, respectively. The low B cell epitopes conservation rate among Omicron sub-lineages underscored the escaping from neutralizing humoral immunity. T cell epitopes of the SARS-CoV-2 were considerably preserved across major Omicron sub-lineages. Conservation levels varied based on the epitope class (higher for CD8+ vs. CD4+), protein (higher for non-spike vs. spike), and clades (higher for 21L, 22F, 23B, 23H, 23D and 24B vs 24A and 24C). Conclusion: Herein, the increased conservation of CD8+ epitopes compared to CD4+ and B cell epitopes is probably attributable to the shorter length of the peptides associated with CD8+ epitopes. The high rate of T-cell epitopes conservation in non-spike proteins among different sub-lineages of the Omicron in this study highlighted the importance of cell-mediated immunity and suggested that non-spike proteins might be more attractive targets for future SARS-CoV-2 vaccines.

    Keywords: SARS-CoV2, Omicron sub-lineages, phylogenetic, epitope variations, Immunity

    Received: 20 Nov 2024; Accepted: 17 Dec 2024.

    Copyright: © 2024 Shabani, Nejati, Yavarian, Sadeghi, Zadheidar, Ahmadi, Ghadirali, Zebardast, Abedi, Najmi, Shafiei-Jandaghi and Mokhtari-Azad. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Ahmad Nejati, Tehran University of Medical Sciences, Tehran, Iran
    Kaveh Sadeghi, Tehran University of Medical Sciences, Tehran, Iran
    Sevrin Zadheidar, Tehran University of Medical Sciences, Tehran, Iran
    Akram Sadat Ahmadi, Tehran University of Medical Sciences, Tehran, Iran
    Monire Ghadirali, Tehran University of Medical Sciences, Tehran, Iran
    Mohammad Hossein Najmi, Tarbiat Modares University, Tehran, 14117-13116, Tehran, Iran
    Nazanin-Zahra Shafiei-Jandaghi, Tehran University of Medical Sciences, Tehran, Iran
    Talat Mokhtari-Azad, Tehran University of Medical Sciences, Tehran, Iran

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.